202 326

Cited 0 times in

Complete Remission Induced by Filgrastim (rhG-CSF) in the Case of Relapsed Acute Lymphoblastic Leukemia after Unrelated Cord Blood Transplantation

Other Title
급성림프구성백혈병 환자의 제대혈이식 후 재발에서 Filgrastim (rhG-CSF)으로 유도한 완전관해
이, 성욱; 정, 현주; 박, 준은
Imsang soa hyŏlaek chongyang, 15(2):134-138, 2008
Journal Title
Imsang soa hyŏlaek chongyang; Clinical Pediatric Hematology-Oncology; 임상소아혈액종양
We report the case of a 13-years-old male patient with relapsed acute lymphoblastic leukemia, after unrelated cord blood transplantation (CBT), who led to complete remission (CR) by Filgrastim (rhG-CSF). This patient achieved CR1 by induction chemotherapy, but the first relapse occurred at 16 months after the time of diagnosis. The CR2 was obtained with chemotherapy, then one HLA mismatched unrelated CBT was performed. Engraftment occurred and the BM aspirate showed 100% donor cells. But a BM aspirate obtained at 10 months showed relapse, with 56.5% blasts and 51.7% donor cells. After chemotherapy with vincristine and corticosteroid, BM aspirate showed partial remission with 6.8% blasts and 93.4% chimerism of donor’s cells. For graft-versus-leukemia effect Filgrastim (3.75μg/kg) was subcutaneously injected daily for 60 days. BM study performed at 1 month after completion of Filgrastim revealed CR3 and 99.8% donor’s cells. The third relapse happened at 6 months after CR3, and the patient died 3 months later although chemotherapy continued.
Acute lymphoblastic leukemiaUmbilical cord transplantationrhG-CSFGraft vs leukemia effect
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Pediatrics & Adolescent Medicine
AJOU Authors
정, 현주박, 준은
Files in This Item:
Clinical Pediatric Hematology-Oncology_15(2)_134-138.pdfDownload
RIS (EndNote)
XLS (Excel)


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.